Gattefossé UK offer innovative lipid excipients and personalized technical support, provided by fully trained experts to accelerate customers’ development programs, for pharmaceutical and veterinary drugs, as well as dietary supplements.

Genvolt is a multinational engineering firm and has been a trailblazer in the technology space for over three decades. Renowned for our innovative solutions, we have recently established ourselves as a leading global player in the manufacture of emerging pioneering pharmaceutical research equipment. Our commitment to excellence is reflected in our extensive collaborations with researchers and institutions globally, particularly in the field of Electrohydrodynamic Atomisation (EHDA).

Genvolt has consistently pushed the boundaries of innovation. Our expertise in Pharmaceutical Engineering Technology has driven the design and development of several low-cost, high-value base platform technologies— built upon groundbreaking collaborative projects that sit at the intersection of science and innovation. These are targeted at revolutionising drug delivery and pharmaceutical research and the advancement of electrospinning and electrospraying technologies, with bespoke end-user design and interface.

Genvolt’s success is built on our dynamic exploration of cutting-edge technology and collaborative excellence. We pride ourselves on our partnerships with leading global researchers and institutions, which have positioned us at the forefront of EHDA research. These collaborations are not only advancing scientific knowledge but also translating into practical, high-impact solutions for the pharmaceutical industry.

Meet our team of experts who are ready to provide personalised advice and support tailored to your specific requirements. Experience live demonstrations of our products and see firsthand how they can benefit your laboratory and research projects.

We invite all attendees to visit our booth to learn more about how Genvolt’s advanced technologies can drive your research forward. Whether you are involved in pharmaceuticals, biotechnology, or academic research, our solutions are crafted to meet your highest expectations and facilitate groundbreaking discoveries.

Hiden Isochema is a world leader and specialist in the design and manufacture of vapor and gas sorption instruments for research, development and production applications.

We offer a range of sorption analyzers and laboratory services for the characterization of interactions with pharmaceuticals including water sorption isotherms, surface area and porosity, amorphous phase content, hydration analysis and the determination of diffusion coefficients and vapor permeation.

Our IGAsorp gravimetric dynamic vapor sorption analyzer is firmly established as a market leader and is used in many high profile academic, R&D and manufacturing environments within the UK and worldwide.

You’ve known us for decades as the makers of Avicel® and METHOCEL™ and many other strong brands, and we’re building on that history while embracing a future of new possibilities. With decades of vital experience in the pharmaceutical industry, we have a proven track record of working with customers around the globe to differentiate drug formulations and solve the toughest challenges. At IFF Pharma Solutions we provide sustainable cellulosics, seaweed extracts, ultrapure biopolymers and specialized synthetic polymers. This is supported by our polymer expertise and problem-solving mindset across the entire drug development pipeline.

IMCD is a leading global distribution partner and formulator of speciality chemicals and ingredients.

IMCD Pharmaceuticals has a network of six dedicated technical centres and more than 250 sales and marketing experts around the globe. We support our customers and partners at every stage of their product development cycle, from synthesis and extraction of active ingredients, right through to the final product. We serve as an end-to-end partner in the pharmaceutical, nutraceutical, biopharma, synthesis, and agrochemical sectors, to advance ideas for a healthy future.

Our unrivalled technical expertise in excipient performance and functionality, together with our regulatory and quality support, enable us to provide added value every step of the way.

Our 30 years of experience (GLP/GCP/GMP) in the development of complex dosage forms helps to drive our partner’s programs forward daily.

With specialist expertise in orally inhaled & nasal drug product development (OINDPs), we provide analytical testing integrated with formulation and clinical manufacturing capabilities, to support a wide range of projects. Our expertise covers small and large molecules – where we have a dedicated facility for biologics characterisation – and selecting the right delivery platform and device technology to suit your needs.

Our expert analytical services include specific aerosol testing for OINDPs, as well as characterisation and QC testing for various classes of molecules, including DNA therapies, peptides, cell & gene therapies, liposomes, nanoparticles and vaccines. We can also run E&L studies and provide regulatory services through our network of laboratories and consultants.

MDPI (Multidisciplinary Digital Publishing Institute), founded in 1996 in Basel, Switzerland, is a pioneer in scholarly open-access publishing with over 400 peer-reviewed journals. MDPI promotes open scientific exchange across all disciplines and is supported by more than 295,000 academic experts committed to providing high-quality services to its authors.

MeltPrep specializes in laboratory equipment for rapid and lossless prototyping of new dosage forms. Our Vacuum Compression Molding (VCM) technology facilitates formulation screening with mg-to-gram-scale sample molding, ensuring homogeneity directly from powders and eliminating air inclusions.

Providing solutions for a wide range of applications, including Hot Melt Extrusion (HME), Amorphous Solid Dispersions (ASD), and implant formulation screening, the VCM Platform stands out as a versatile tool for pharmaceutical innovation. In addition to a variety of standard sample sizes, it enables the molding of single prototypes to screen dosage forms with complex geometries using Free-D Molding and facilitates the production of filaments for FDM 3D printing through the VCM Filament Molder.

Visit our exhibit at PharmSci 2025 to explore how our VCM technology is accelerating drug formulation and unlocking new possibilities in pharmaceutical development.

PCI is a leading global CDMO, offering integrated end-to-end drug development, manufacturing, and packaging services to accelerate speed to market and support commercial success. With more than 90 product launches annually and over 50 years of industry experience, we deliver proven expertise across the healthcare landscape. Operating 30 sites in seven countries, PCI provides advanced technologies and ongoing investment to support every stage of the drug development life cycle – from manufacturing and clinical trial supply to commercialisation. Our clients see us as a trusted extension of their team, working together with a shared commitment to delivering life-changing therapies to patients worldwide.

Pharmaron is a premier service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities and established a broad spectrum of research, development, and manufacturing service capabilities throughout the entire drug discovery, preclinical, and clinical development process across multiple therapeutic modalities, including small molecules, biologics, and CGT products. With over 21,000 employees and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in delivering R&D solutions to its partners in North America, Europe, Japan, and China.

Pion supports the development of lifesaving and life-enhancing drugs by providing tools for drug developers, formulations scientists, and pharmaceutical production. For early-stage drug developers, our cutting-edge analytical technologies and services enable in vitro measurements that provide essential data to improve candidate selection and formulations decisions. Later in development, high-pressure homogenizers enable particle size reduction and ensure material consistency from bench- to production-scale.

Upperton Pharma Solutions is a UK-based contract development and manufacturing organisation (CDMO) specialising in formulation development and clinical trial manufacturing for oral solids, liquids, semi-solids, nasal and inhalation drug products.

Our capabilities and services include Formulation development, Phase 1 to Phase 3 clinical supply, Process scale-up and optimisation, Registration activities and Analytical development and validation. Our defining traits lie in our adaptability and nimbleness, enabling rapid product introduction within 4-6 weeks, and flexibility ensuring that we can problem-solve, meet timescales and deliver solutions that meet patient targets.

Ytron-Quadro have recently celebrated their 40th year of providing processing solutions to the Pharmaceutical and other Manufacturing Sectors.

Established in 1984 by Dudley Bradley the company started by representing Quadro, the originator of the Comil, and YTRON mixing and dispersion equipment.

Since starting, the range of process equipment offered by Ytron-Quadro has grown and now includes Fitzpatrick milling and roller compaction, VMI mixing systems for creams and gels and Labocontrole sampling devices for powders and liquids.

Ytron-Quadro remains a family run company with 3 generations of the Bradley family active in the business.

To find out more click on the link to our website below or visit our stand at PharmSci 2025.